SCHEMBL812495

SCHEMBL812495

CCCC1c2ccccc2-c2cccc([Hf]c3cccc4c3C(CCC)c3ccccc3-4)c21

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 1/20 0.39
ACHE P22303 2/20 0.36
BCHE P06276 1/20 0.36
CYP1A2 P05177 1/20 0.33
CYP2C19 P33261 1/20 0.33
CA1 P00915 1/20 0.32
CA2 P00918 1/20 0.32
GPR3 P46089 1/20 0.32
TDO2 P48775 1/20 0.31
CHRM2 P08172 1/20 0.30
HTR1A P08908 1/20 0.30
ADRA2A P08913 1/20 0.30
CHRM1 P11229 1/20 0.30
DRD1 P21728 1/20 0.30
SLC6A2 P23975 1/20 0.30
SLC6A4 P31645 1/20 0.30
ADRA1A P35348 1/20 0.30
OPRM1 P35372 1/20 0.30
DRD3 P35462 1/20 0.30
SLC6A3 Q01959 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30638592 1.00 HTR2A (0.39) HTR2AACHEBCHECYP1A2CYP2C19
SCHEMBL30638595 0.92 ACHE (0.41) HTR2AACHEBCHECHRM2HTR1A
SCHEMBL815385 0.92 ACHE (0.41) HTR2AACHEBCHECHRM2HTR1A
Hydrochloric Acid SCHEMBL2275702 0.79 HTR2A (0.38) HTR2AACHEBCHECYP1A2CYP2C19
SCHEMBL27638219 0.79 HTR2A (0.40) HTR2AACHEBCHECYP1A2CYP2C19
SCHEMBL1996543 0.78 HTR2A (0.54) HTR2AACHEBCHECYP1A2CYP2C19
SCHEMBL6759445 0.77 HTR2A (0.39) HTR2AACHEBCHECYP1A2CYP2C19
SCHEMBL30638591 0.76
SCHEMBL2275700 0.75 HTR2A (0.37) HTR2AACHEBCHECYP1A2CYP2C19
SCHEMBL4556486 0.74 HTR2A (0.36) HTR2AACHEBCHECYP1A2CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 131 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114901391-B System and method for producing supported catalysts 埃克森美孚化学专利公司 2024-11-26 CN disclosed
US-11618791-B2 Systems and methods for producing a supported catalyst EXXONMOBIL CHEMICAL PATENTS INC. (US) 2023-04-04 US disclosed
CN-114901391-A System and method for producing supported catalysts 埃克森美孚化学专利公司 2022-08-12 CN disclosed
US-20210155723-A1 Systems and Methods for Producing a Supported Catalyst EXXONMOBIL CHEMICAL PATENTS INC (US) 2021-05-27 US disclosed
EP-2872539-B1 INCREASED POLYMER MELT FLOW RATIO VIA FEED OF A SUPPORTED CATALYST SATURATED WITH A SELECTED LIQUID AGENT UNIVATION TECH LLC (US) 2020-12-09 EP disclosed
CN-108383935-A The polymer melt flow ratio for the raising that the supported catalyst being saturated by the liquid reagent of supply selection obtains 尤尼威蒂恩技术有限责任公司 2018-08-10 CN disclosed
US-9512254-B2 Increased polymer melt flow ratio via feed of a supported catalyst saturated with a selected liquid agent UNIVATION TECHNOLOGIES, LLC (US) 2016-12-06 US disclosed
EP-1716183-B1 DE-FOAMING SPRAY DRIED CATALYST SLURRIES UNIVATION TECH LLC (US) 2016-04-13 EP disclosed
US-20160032034-A1 HAFNOCENE CATALYZED POLYETHYLENE FILMS HAVING RAPID CLING DEVELOPMENT UNIVATION TECHNOLOGIES, LLC (US) 2016-02-04 US disclosed
EP-2970610-A2 HAFNOCENE CATALYZED POLYETHYLENE FILMS HAVING RAPID CLING DEVELOPMENT Univation Technologies, LLC (US) 2016-01-20 EP disclosed
WO-2004022230-A1 PROCESS FOR PRODUCING FLUORINATED CATALYSTS UNIVATION TECHNOLOGIES, LLC (US) 2004-03-18 WO disclosed
WO-2004022607-A1 BIMODAL POLYOLEFIN PRODUCTION PROCESS AND FILMS THEREFROM UNIVATION TECHNOLOGIES, LLC (US) 2004-03-18 WO disclosed
WO-2004022605-A1 GAS PHASE POLYMERIZATION PROCESS UNIVATION TECHNOLOGIES, LLC (US) 2004-03-18 WO disclosed
US-20040044153-A1 Gas phase polymerization process UNIVATION TECHNOLOGIES, LLC 2004-03-04 US disclosed
US-20040044154-A1 Bimodal polyolefin production process and films therefrom UNIVATION TECHNOLOGIES, LLC 2004-03-04 US disclosed
US-20040043893-A1 Process for producing fluorinated catalysts UNIVATION TECHNOLOGIES, LLC 2004-03-04 US disclosed
WO-2004003037-A1 HALOGEN SUBSTITUTED CATALYST SYSTEM FOR OLEFIN POLYMERIZATION UNIVATION TECHNOLOGIES, LLC. (US) 2004-01-08 WO disclosed
WO-2004003032-A2 HETEROCYCLIC NITROGEN-CONTAINING ACTIVATORS AND CATALYST SYSTEMS FOR OLEFIN POLYMERIZATION UNIVATION TECHNOLOGIES, LLC (US) 2004-01-08 WO disclosed
US-20030171514-A1 Polymerization catalyst activator complexes and their use in a polymerization process DOW GLOBAL TECHNOLOGIES LLC 2003-09-11 US disclosed
WO-2003064435-A1 POLYMERIZATION CATALYST ACTIVATOR COMPLEXES AND THEIR USE IN A POLYMERIZATION PROCESS UNIVATION TECHNOLOGIES, LLC (US) 2003-08-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040043893-A1 Process for producing fluorinated catalysts FLI1, AFF1, INF2 HTR2A 3132/4885ACHE 1930/4885BCHE 3850/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.